ClinConnect ClinConnect Logo
Search / Trial NCT01128868

Proximal Femur Locking Compression Plates Versus Trochanteric Nails

Launched by AO CLINICAL INVESTIGATION AND PUBLISHING DOCUMENTATION · May 21, 2010

Trial Information

Current as of April 25, 2025

Completed

Keywords

Reverse Oblique Intertrochanteric Fractures Reverse Oblique Subtrochanteric Fractures

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years
  • Patients with closed or type 1 open reverse oblique intertrochanteric fractures (AO 31 - A3) or subtrochanteric fractures (transverse fracture line, main fracture line maximum 5 cm distal from the lesser trochanter; proximal extension of fracture allowed)
  • Definitive fracture fixation with either a proximal femur locking plate or an intertrochanteric nail within 4 days after accident
  • Signed written informed consent (by the subject or legal guardian) and agreement to attend the planned FUs
  • Able to understand and read country national language at an elementary level
  • Exclusion Criteria:
  • Pathologic fracture
  • Polytrauma
  • Any displacement of a femoral neck fracture
  • Additional fracture of one of the lower extremities that significantly affects the functional outcome
  • Additional injury of the lower limb that significantly affects the functional outcome
  • Fractures of the upper extremity if it affects the mobility of the patient
  • Type 2 or 3 open fracture
  • Drug or alcohol abuse
  • Active malignancy
  • ASA class V and VI
  • Inability to walk independently prior to injury
  • Neurological and psychiatric disorders that would preclude reliable assessment
  • Patient is not able to come to the regular FUs
  • Patients who have participated in any other device or drug related clinical trial within the previous month
  • Pregnancy (tested with a urine pregnancy test) or women planning to conceive within the study period

Trial Officials

Beate P. Hanson, MD

Study Director

AO Clinical Investigation and Documentation, Davos, Switzerland

About Ao Clinical Investigation And Publishing Documentation

AO Clinical Investigation and Publishing Documentation is a leading organization dedicated to advancing medical research through the rigorous evaluation of clinical trials. Specializing in the design, implementation, and dissemination of clinical studies, AO focuses on enhancing patient outcomes and contributing to the body of scientific knowledge. With a commitment to ethical standards and regulatory compliance, the organization collaborates with healthcare professionals and institutions to ensure high-quality data collection and analysis. Their expertise in publishing ensures that findings are effectively communicated to the medical community, fostering innovation and informed decision-making in patient care.

Locations

Woolloongabba, Queensland, Australia

Chur, , Switzerland

Lucerne, , Switzerland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials